Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04WFL
|
|||
Former ID |
DAP000391
|
|||
Drug Name |
Trastuzumab
|
|||
Synonyms |
Herceptin; Herceptin (TN); Trastuzumab (INN); Trastuzumab (genetical recombination); Trastuzumab (genetical recombination) (JAN); Trastuzumab (ERBB2 mAb inhibitor)
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Approved | [1], [2], [3] | |
Gastric adenocarcinoma [ICD-11: 2B72; ICD-9: 151] | Application submitted | [4] | ||
HER2-positive breast cancer [ICD-11: 2C60-2C65] | Application submitted | [4] | ||
Therapeutic Class |
Anticancer Agents
|
|||
Company |
Roche; Genentech
|
|||
PubChem Substance ID | ||||
ADReCS Drug ID | BADD_D02264 | |||
SuperDrug ATC ID |
L01XC03
|
|||
SuperDrug CAS ID |
cas=180288691
|
Drug Resistance Mutation (DRM) | Top | |||
---|---|---|---|---|
DRM | DRM Info |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5082). | |||
REF 2 | Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651. | |||
REF 3 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 5 | Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study. Melanoma Res. 2004 Jun;14(3):207-10. | |||
REF 6 | Knockouts model the 100 best-selling drugs--will they model the next 100 Nat Rev Drug Discov. 2003 Jan;2(1):38-51. | |||
REF 7 | Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines. Cancer Immunol Immunother. 2002 Jan;50(11):569-87. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.